Scarica l'app Stockscreener
107.39
4.56%
4.68
Dopo l'orario di chiusura:
123.65
16.26
+15.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Precedente Chiudi:
$102.71
Aprire:
$95.21
Volume 24 ore:
13.31M
Relative Volume:
5.11
Capitalizzazione di mercato:
$20.76B
Reddito:
$29.52M
Utile/perdita netta:
$-567.06M
Rapporto P/E:
-29.34
EPS:
-3.66
Flusso di cassa netto:
$-551.11M
1 W Prestazione:
+34.83%
1M Prestazione:
+34.14%
6M Prestazione:
+194.70%
1 anno Prestazione:
+141.76%
Intervallo 1D:
$94.52
$112.43
Intervallo di 1 settimana:
$76.28
$112.43
Portata 52W:
$29.17
$112.43
Revolution Medicines Inc Stock (RVMD) Company Profile
Nome
Revolution Medicines Inc
Settore
Industria
Telefono
415-766-3638
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Confronta RVMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
107.39 | 19.86B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-11-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-10-16 | Ripresa | Stifel | Buy |
| 2025-09-12 | Ripresa | Raymond James | Strong Buy |
| 2025-09-05 | Iniziato | Truist | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-08-15 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2024-07-16 | Reiterato | Needham | Buy |
| 2024-07-12 | Iniziato | Barclays | Overweight |
| 2024-07-08 | Iniziato | Jefferies | Buy |
| 2024-04-12 | Reiterato | Needham | Buy |
| 2024-04-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Iniziato | Piper Sandler | Overweight |
| 2024-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-04 | Iniziato | Wedbush | Outperform |
| 2023-11-16 | Iniziato | Raymond James | Outperform |
| 2023-02-28 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-10-21 | Iniziato | Oppenheimer | Outperform |
| 2022-05-20 | Iniziato | BofA Securities | Neutral |
| 2022-03-01 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-08-12 | Downgrade | Goldman | Buy → Neutral |
| 2021-05-18 | Iniziato | Goldman | Buy |
| 2020-05-21 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-09 | Iniziato | Cowen | Outperform |
| 2020-03-09 | Iniziato | Guggenheim | Buy |
| 2020-03-09 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Merck Reportedly in Talks to Buy Revolution in Up to $32 Billion Deal - MarketScreener
Revolution Medicines Stock Pre-Market (+15%) : FDA Grants Breakthrough Therapy Designation for Zoldonrasib - Trefis
Revolution Medicines jumps on report AbbVie nears takeover - MSN
Merck Reportedly In Talks to Buy Biotech Firm Revolution Medicines for Up to US$32B - AASTOCKS.com
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent Share Price Surge? - simplywall.st
Revolution Medicines takeout speculation spotlight shines on Merck & Co. - FirstWord
Merck, not AbbVie, in talks to buy biotech Revolution Medicines, FT says - Crain's Chicago Business
Merck (MRK) Eyes Acquisition of Revolution Medicines (RVMD) - GuruFocus
Revolution Medicines Stock Soars: Time to Buy? - timothysykes.com
Merck in talks to buy biotech Revolution in up to $32 billion deal, FT reports - Reuters
Why Revolution Medicines’ Stock Is Suddenly Under Pressure - TipRanks
Price tag of $28bn to $32bn was being discussed as part of Merck-Revolution Medicines dealFT - MarketScreener
Merck (MRK) Reportedly in Acquisition Discussions with Revolutio - GuruFocus
Merck might buy Revolution Medicines - breakingthenews.net
Merck in talks to buy biotech Revolution Medicines, FT reports By Reuters - Investing.com
Revolution Medicines stock rises on Merck acquisition talks By Investing.com - Investing.com Nigeria
Merck Looks To Buy Cancer Drugmaker Revolution Medicines: Report - Stocktwits
Revolution Medicines stock rises on Merck acquisition talks - Investing.com
Merck in talks to buy biotech Revolution Medicines, FT reports - Yahoo Finance
Merck in Deal Talks With Biotech Revolution Medicines, FT Says - Bloomberg.com
Why Revolution Medicines Inc. Equity Warrant stock remains resilient2025 Bull vs Bear & Proven Capital Preservation Methods - ulpravda.ru
Merck in talks to buy biotech Revolution Medicines, Financial Times reports - TradingView — Track All Markets
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times
Will Revolution Medicines Inc. Equity Warrant stock deliver shareholder value2025 Support & Resistance & Stepwise Swing Trade Plans - ulpravda.ru
AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders - TechStock²
AbbVie Stock Drops After Guidance Update, Wolfe Downgrade And Deal Denial - Benzinga
What's Going With Cancer Biotech Erasca Stock On Thursday? - Benzinga
Investors Purchase Large Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Shares Gap DownTime to Sell? - MarketBeat
What sentiment indicators say about Revolution Medicines Inc. stockDividend Yield Trends & Free Stock Trading Signal Access - bollywoodhelpline.com
AbbVie denies it’s in talks to buy Revolution Medicines. Both stocks are falling. - MSN
Will Revolution Medicines Inc. stock maintain dividend yieldJuly 2025 Decliners & Weekly Top Stock Performers List - ulpravda.ru
Revolution Medicines (RVMD) Gains FDA Breakthrough Status for Ca - GuruFocus
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader - FinancialContent
RVMD Stock Hits a Record High on Rumored Takeover Interest - The Globe and Mail
AbbVie says it’s not in talks to buy Revolution Medicines; WSJ reports another suitor may prevail - Sherwood News
AbbVie, Revolution Medicines Stocks Fall After Drugmaker Denies Takeover Report - Barron's
KRAS Inhibitors Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Pfizer, Roche, Chugai, Genentech, Revolution Medicines, Eli Lilly, Merck, Taiho, Astex Pharma, Elicio - Barchart.com
Lockheed, Northrop, Alphabet, Revolution Medicines, AbbVie, Costco, and More Movers - Barron's
Revolution Medicines (RVMD) Gains FDA Breakthrough Therapy Desig - GuruFocus
FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com India
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib - The Manila Times
Revolution Medicines Announces FDA Breakthrough Therapy Designation For Zoldonrasib - TradingView — Track All Markets
AbbVie (ABBV) Stock Falls After Company Denies Revolution Medicines Buyout Talks - Blockonomi
FDA fast-tracks development of new drug for KRAS G12D lung cancer - Stock Titan
Northrop, Lockheed, Alphabet, Revolution Medicines, AbbVie, Costco, and More Movers - Barron's
These stocks are moving the most today: Northrop, Lockheed, Alphabet, Revolution Medicines, AbbVie, Costco, and more - MSN
AbbVie denies media reports of talks to buy Revolution Medicines - WKZO
Revolution Medicines (RVMD) stock slips in premarket as AbbVie denies takeover talks, deal buzz lingers - TechStock²
Northrop, Lockheed, Alphabet, Revolution Medicines, Costco, and More Market Movers - Barron's
Revolution Medicines Inc Azioni (RVMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):